Medstar Health Research Institute .
Baltimore, Maryland 21239
7 studies enrolling now · 27 studies all time
What they study most
Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Adenocarcinoma, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Fibrillation, Postoperative, Avascular Necrosis of Femoral Condyle, CIED Related Infection, Carcinoma, Carcinoma, Large Cell, Chronic Kidney Disease, Collagen Disorders
Studies at this site
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
- BoxX-NoAF Clinical Trial — Recruiting now
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
- The PREDICT Registry: — Recruiting now
- The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation — Recruiting now
- Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone — Recruiting now
- Persona SoluTion PPS Femur PMCF — Enrolling by invitation
- Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients — Stopped early
- Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) — Completed
- Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 — Stopped early
- AdaptResponse Clinical Trial — Completed
- A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
- Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy — Completed
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
- Personalized CRT - MPP Post Approval Study — Completed
- Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm — Completed
- Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer — Stopped early
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- Quadripolar Pacing Post Approval Study — Completed
- Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly — Completed
- AngelMed for Early Recognition and Treatment of STEMI — Completed
- Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE